Supraclavicular lymphadenopathy after COVID-19 vaccination

Pediatr Blood Cancer. 2022 May;69(5):e29516. doi: 10.1002/pbc.29516. Epub 2021 Dec 16.

Authors

Kelsey Larkin¹, Archana Sharma², Richard Drachtman², Gratian Salaru³

Affiliations

¹ Department of Pediatrics, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
² Division of Pediatric Hematology, Rutgers Cancer Institute, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
³ Department of Pathology, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

PMID: 34913588
DOI: 10.1002/pbc.29516

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Lymphadenopathy* / etiology
Positron Emission Tomography Computed Tomography
Vaccination / adverse effects

Substances

COVID-19 Vaccines